Molecular Biomarkers-North America Market Status and Trend Report 2013-2023
Report Summary
Molecular Biomarkers-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Biomarkers industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Molecular Biomarkers 2013-2017, and development forecast 2018-2023
Main market players of Molecular Biomarkers in North America, with company and product introduction, position in the Molecular Biomarkers market
Market status and development trend of Molecular Biomarkers by types and applications
Cost and profit status of Molecular Biomarkers, and marketing status
Market growth drivers and challenges
The report segments the North America Molecular Biomarkers market as:
North America Molecular Biomarkers Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Molecular Biomarkers Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Genomics
Proteomics
Others
North America Molecular Biomarkers Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medicine
Biology
Other
North America Molecular Biomarkers Market: Players Segment Analysis (Company and Product introduction, Molecular Biomarkers Sales Volume, Revenue, Price and Gross Margin):
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Molecular Biomarkers-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Biomarkers industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Molecular Biomarkers 2013-2017, and development forecast 2018-2023
Main market players of Molecular Biomarkers in North America, with company and product introduction, position in the Molecular Biomarkers market
Market status and development trend of Molecular Biomarkers by types and applications
Cost and profit status of Molecular Biomarkers, and marketing status
Market growth drivers and challenges
The report segments the North America Molecular Biomarkers market as:
North America Molecular Biomarkers Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Molecular Biomarkers Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Genomics
Proteomics
Others
North America Molecular Biomarkers Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medicine
Biology
Other
North America Molecular Biomarkers Market: Players Segment Analysis (Company and Product introduction, Molecular Biomarkers Sales Volume, Revenue, Price and Gross Margin):
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MOLECULAR BIOMARKERS
1.1 Definition of Molecular Biomarkers in This Report
1.2 Commercial Types of Molecular Biomarkers
1.2.1 Genomics
1.2.2 Proteomics
1.2.3 Others
1.3 Downstream Application of Molecular Biomarkers
1.3.1 Medicine
1.3.2 Biology
1.3.3 Other
1.4 Development History of Molecular Biomarkers
1.5 Market Status and Trend of Molecular Biomarkers 2013-2023
1.5.1 North America Molecular Biomarkers Market Status and Trend 2013-2023
1.5.2 Regional Molecular Biomarkers Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Biomarkers in North America 2013-2017
2.2 Consumption Market of Molecular Biomarkers in North America by Regions
2.2.1 Consumption Volume of Molecular Biomarkers in North America by Regions
2.2.2 Revenue of Molecular Biomarkers in North America by Regions
2.3 Market Analysis of Molecular Biomarkers in North America by Regions
2.3.1 Market Analysis of Molecular Biomarkers in United States 2013-2017
2.3.2 Market Analysis of Molecular Biomarkers in Canada 2013-2017
2.3.3 Market Analysis of Molecular Biomarkers in Mexico 2013-2017
2.4 Market Development Forecast of Molecular Biomarkers in North America 2018-2023
2.4.1 Market Development Forecast of Molecular Biomarkers in North America 2018-2023
2.4.2 Market Development Forecast of Molecular Biomarkers by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Molecular Biomarkers in North America by Types
3.1.2 Revenue of Molecular Biomarkers in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Molecular Biomarkers in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Biomarkers in North America by Downstream Industry
4.2 Demand Volume of Molecular Biomarkers by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Biomarkers by Downstream Industry in United States
4.2.2 Demand Volume of Molecular Biomarkers by Downstream Industry in Canada
4.2.3 Demand Volume of Molecular Biomarkers by Downstream Industry in Mexico
4.3 Market Forecast of Molecular Biomarkers in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR BIOMARKERS
5.1 North America Economy Situation and Trend Overview
5.2 Molecular Biomarkers Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR BIOMARKERS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Molecular Biomarkers in North America by Major Players
6.2 Revenue of Molecular Biomarkers in North America by Major Players
6.3 Basic Information of Molecular Biomarkers by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Biomarkers Major Players
6.3.2 Employees and Revenue Level of Molecular Biomarkers Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR BIOMARKERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Alere
7.1.1 Company profile
7.1.2 Representative Molecular Biomarkers Product
7.1.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Alere
7.2 Atossa Genetics
7.2.1 Company profile
7.2.2 Representative Molecular Biomarkers Product
7.2.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Atossa Genetics
7.3 Biophysical
7.3.1 Company profile
7.3.2 Representative Molecular Biomarkers Product
7.3.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Biophysical
7.4 Abbott
7.4.1 Company profile
7.4.2 Representative Molecular Biomarkers Product
7.4.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Abbott
7.5 BioCept
7.5.1 Company profile
7.5.2 Representative Molecular Biomarkers Product
7.5.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioCept
7.6 BioTheranostics
7.6.1 Company profile
7.6.2 Representative Molecular Biomarkers Product
7.6.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioTheranostics
7.7 DiagnoCure
7.7.1 Company profile
7.7.2 Representative Molecular Biomarkers Product
7.7.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of DiagnoCure
7.8 GenomeDx
7.8.1 Company profile
7.8.2 Representative Molecular Biomarkers Product
7.8.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of GenomeDx
7.9 Genomic Health
7.9.1 Company profile
7.9.2 Representative Molecular Biomarkers Product
7.9.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Genomic Health
7.10 Gen-Probe
7.10.1 Company profile
7.10.2 Representative Molecular Biomarkers Product
7.10.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Gen-Probe
7.11 Life Technologies
7.11.1 Company profile
7.11.2 Representative Molecular Biomarkers Product
7.11.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Life Technologies
7.12 20/20 GeneSystems
7.12.1 Company profile
7.12.2 Representative Molecular Biomarkers Product
7.12.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of 20/20 GeneSystems
7.13 Cynvenio
7.13.1 Company profile
7.13.2 Representative Molecular Biomarkers Product
7.13.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Cynvenio
7.14 Dako (Agilent)
7.14.1 Company profile
7.14.2 Representative Molecular Biomarkers Product
7.14.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Dako (Agilent)
7.15 Epic Sciences
7.15.1 Company profile
7.15.2 Representative Molecular Biomarkers Product
7.15.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Epic Sciences
7.16 Foundation Medicine
7.17 Genomic Health
7.18 Molecular Response
7.19 Nodality
7.20 PGD
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR BIOMARKERS
8.1 Industry Chain of Molecular Biomarkers
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR BIOMARKERS
9.1 Cost Structure Analysis of Molecular Biomarkers
9.2 Raw Materials Cost Analysis of Molecular Biomarkers
9.3 Labor Cost Analysis of Molecular Biomarkers
9.4 Manufacturing Expenses Analysis of Molecular Biomarkers
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR BIOMARKERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Molecular Biomarkers in This Report
1.2 Commercial Types of Molecular Biomarkers
1.2.1 Genomics
1.2.2 Proteomics
1.2.3 Others
1.3 Downstream Application of Molecular Biomarkers
1.3.1 Medicine
1.3.2 Biology
1.3.3 Other
1.4 Development History of Molecular Biomarkers
1.5 Market Status and Trend of Molecular Biomarkers 2013-2023
1.5.1 North America Molecular Biomarkers Market Status and Trend 2013-2023
1.5.2 Regional Molecular Biomarkers Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Biomarkers in North America 2013-2017
2.2 Consumption Market of Molecular Biomarkers in North America by Regions
2.2.1 Consumption Volume of Molecular Biomarkers in North America by Regions
2.2.2 Revenue of Molecular Biomarkers in North America by Regions
2.3 Market Analysis of Molecular Biomarkers in North America by Regions
2.3.1 Market Analysis of Molecular Biomarkers in United States 2013-2017
2.3.2 Market Analysis of Molecular Biomarkers in Canada 2013-2017
2.3.3 Market Analysis of Molecular Biomarkers in Mexico 2013-2017
2.4 Market Development Forecast of Molecular Biomarkers in North America 2018-2023
2.4.1 Market Development Forecast of Molecular Biomarkers in North America 2018-2023
2.4.2 Market Development Forecast of Molecular Biomarkers by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Molecular Biomarkers in North America by Types
3.1.2 Revenue of Molecular Biomarkers in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Molecular Biomarkers in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Biomarkers in North America by Downstream Industry
4.2 Demand Volume of Molecular Biomarkers by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Biomarkers by Downstream Industry in United States
4.2.2 Demand Volume of Molecular Biomarkers by Downstream Industry in Canada
4.2.3 Demand Volume of Molecular Biomarkers by Downstream Industry in Mexico
4.3 Market Forecast of Molecular Biomarkers in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR BIOMARKERS
5.1 North America Economy Situation and Trend Overview
5.2 Molecular Biomarkers Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR BIOMARKERS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Molecular Biomarkers in North America by Major Players
6.2 Revenue of Molecular Biomarkers in North America by Major Players
6.3 Basic Information of Molecular Biomarkers by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Biomarkers Major Players
6.3.2 Employees and Revenue Level of Molecular Biomarkers Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR BIOMARKERS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Alere
7.1.1 Company profile
7.1.2 Representative Molecular Biomarkers Product
7.1.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Alere
7.2 Atossa Genetics
7.2.1 Company profile
7.2.2 Representative Molecular Biomarkers Product
7.2.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Atossa Genetics
7.3 Biophysical
7.3.1 Company profile
7.3.2 Representative Molecular Biomarkers Product
7.3.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Biophysical
7.4 Abbott
7.4.1 Company profile
7.4.2 Representative Molecular Biomarkers Product
7.4.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Abbott
7.5 BioCept
7.5.1 Company profile
7.5.2 Representative Molecular Biomarkers Product
7.5.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioCept
7.6 BioTheranostics
7.6.1 Company profile
7.6.2 Representative Molecular Biomarkers Product
7.6.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of BioTheranostics
7.7 DiagnoCure
7.7.1 Company profile
7.7.2 Representative Molecular Biomarkers Product
7.7.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of DiagnoCure
7.8 GenomeDx
7.8.1 Company profile
7.8.2 Representative Molecular Biomarkers Product
7.8.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of GenomeDx
7.9 Genomic Health
7.9.1 Company profile
7.9.2 Representative Molecular Biomarkers Product
7.9.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Genomic Health
7.10 Gen-Probe
7.10.1 Company profile
7.10.2 Representative Molecular Biomarkers Product
7.10.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Gen-Probe
7.11 Life Technologies
7.11.1 Company profile
7.11.2 Representative Molecular Biomarkers Product
7.11.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Life Technologies
7.12 20/20 GeneSystems
7.12.1 Company profile
7.12.2 Representative Molecular Biomarkers Product
7.12.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of 20/20 GeneSystems
7.13 Cynvenio
7.13.1 Company profile
7.13.2 Representative Molecular Biomarkers Product
7.13.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Cynvenio
7.14 Dako (Agilent)
7.14.1 Company profile
7.14.2 Representative Molecular Biomarkers Product
7.14.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Dako (Agilent)
7.15 Epic Sciences
7.15.1 Company profile
7.15.2 Representative Molecular Biomarkers Product
7.15.3 Molecular Biomarkers Sales, Revenue, Price and Gross Margin of Epic Sciences
7.16 Foundation Medicine
7.17 Genomic Health
7.18 Molecular Response
7.19 Nodality
7.20 PGD
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR BIOMARKERS
8.1 Industry Chain of Molecular Biomarkers
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR BIOMARKERS
9.1 Cost Structure Analysis of Molecular Biomarkers
9.2 Raw Materials Cost Analysis of Molecular Biomarkers
9.3 Labor Cost Analysis of Molecular Biomarkers
9.4 Manufacturing Expenses Analysis of Molecular Biomarkers
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR BIOMARKERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
